Education
About Us
Working with TipRanks
Follow Us
Venus Remedies Limited (IN:VENUSREM)
:VENUSREM
Total Valuation
Venus Remedies Limited has a market cap or net worth of ₹9.72B. The enterprise value is ₹2.38B.
Market Cap₹9.72B
Enterprise Value₹2.38B
Share Statistics
Venus Remedies Limited has 13,366,988 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,366,988
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Venus Remedies Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.45%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)4.45%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee5.46M
Profits Per Employee381.80K
Employee Count1,187
Asset Turnover0.91
Inventory Turnover4.79
Valuation Ratios
The current PE Ratio of Venus Remedies Limited is 13.8. Venus Remedies Limited’s PEG ratio is 0.16.
PE Ratio13.8
PS Ratio0.65
PB Ratio0.75
Price to Fair Value0.75
Price to FCF5.20
Price to Operating Cash Flow0.00
PEG Ratio0.16
Income Statement
In the last 12 months, Venus Remedies Limited had revenue of 6.48B and earned 453.20M in profits. Earnings per share was 33.90.
Revenue6.48B
Gross Profit1.66B
Operating Income410.30M
Pretax Income718.30M
Net Income453.20M
EBITDA944.10M
Earnings Per Share (EPS)33.90
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Venus Remedies Limited pays an annual dividend of ₹3, resulting in a dividend yield of ―
Dividend Per Share₹3
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.06
52-Week Price Change151.46%
50-Day Moving Average685.34
200-Day Moving Average488.26
Relative Strength Index (RSI)47.31
Average Volume (3m)2.33K
Important Dates
Venus Remedies Limited upcoming earnings date is Feb 18, 2026, TBA (Confirmed).
Last Earnings DateNov 10, 2025
Next Earnings DateFeb 18, 2026
Ex-Dividend Date―
Financial Position
Venus Remedies Limited as a current ratio of 3.31, with Debt / Equity ratio of 0.00%
Current Ratio3.31
Quick Ratio2.58
Debt to Market Cap<0.01
Net Debt to EBITDA-0.83
Interest Coverage Ratio586.14
Taxes
In the past 12 months, Venus Remedies Limited has paid 265.10M in taxes.
Income Tax265.10M
Effective Tax Rate0.37
Enterprise Valuation
Venus Remedies Limited EV to EBITDA ratio is 3.65, with an EV/FCF ratio of 4.24.
EV to Sales0.53
EV to EBITDA3.65
EV to Free Cash Flow4.24
EV to Operating Cash Flow3.79
Balance Sheet
Venus Remedies Limited has ₹1.56B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹1.56B billion.
Cash & Marketable Securities₹1.56B
Total Debt₹0.00
Net Cash₹1.56B
Net Cash Per Share₹116.93
Tangible Book Value Per Share₹341.24
Margins
Gross margin is 33.11%, with operating margin of 6.33%, and net profit margin of 7.00%.
Gross Margin33.11%
Operating Margin6.33%
Pretax Margin11.09%
Net Profit Margin7.00%
EBITDA Margin14.57%
EBIT Margin11.10%
Analyst Forecast
The average price target for Venus Remedies Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast13.32%
EPS Growth Forecast218.38%